Hemodynamic and respiratory effects of dexmedetomidine sedation in critically ill Covid-19 patients: A retrospective cohort study.

Panu UusaloMika ValtonenMikko J Järvisalo

Published in: Acta anaesthesiologica Scandinavica (2021)

Dexmedetomidine is an effective sedative for CV19 patients and may improve their oxygenation. However, dexmedetomidine administration is associated with marked decline in HR and with a high incidence of bradycardia in patients with CV19.

Keyphrases

end stage renal disease
cardiac surgery
ejection fraction
chronic kidney disease
newly diagnosed
sars cov
prognostic factors
risk factors
peritoneal dialysis
intensive care unit
mechanical ventilation
blood flow
acute respiratory distress syndrome